Dose et al., 2011 - Google Patents
NMR profiling of histone deacetylase and acetyl-transferase activities in real timeDose et al., 2011
- Document ID
- 11998234711426891262
- Author
- Dose A
- Liokatis S
- Theillet F
- Selenko P
- Schwarzer D
- Publication year
- Publication venue
- ACS chemical biology
External Links
Snippet
Histone deacetylases (HDACs) and histone acetyl-transferases (HATs) are universal regulators of eukaryotic transcriptional activity and emerging therapeutic targets for human diseases. Here we describe the generation of isotope-labeled deacetylation and acetylation …
- 108090000353 Histone deacetylases 0 title abstract description 185
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
- G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
- G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
- G01N33/502—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics for testing non-proliferative effects
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
- G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
- G01N33/6803—General methods of protein analysis not limited to specific proteins or families of proteins
- G01N33/6842—Proteomic analysis of subsets of protein mixtures with reduced complexity, e.g. membrane proteins, phosphoproteins, organelle proteins
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
- G01N2333/90—Enzymes; Proenzymes
- G01N2333/914—Hydrolases (3)
- G01N2333/978—Hydrolases (3) acting on carbon to nitrogen bonds other than peptide bonds (3.5)
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2500/00—Screening for compounds of potential therapeutic value
- G01N2500/04—Screening involving studying the effect of compounds C directly on molecule A (e.g. C are potential ligands for a receptor A, or potential substrates for an enzyme A)
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2500/00—Screening for compounds of potential therapeutic value
- G01N2500/10—Screening for compounds of potential therapeutic value involving cells
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Dose et al. | NMR profiling of histone deacetylase and acetyl-transferase activities in real time | |
Yang et al. | Bioorthogonal chemical reporters for monitoring protein acetylation | |
Adibekian et al. | Confirming target engagement for reversible inhibitors in vivo by kinetically tuned activity-based probes | |
Olson et al. | An unbiased approach to identify endogenous substrates of “histone” deacetylase 8 | |
Choudhary et al. | The growing landscape of lysine acetylation links metabolism and cell signalling | |
Huang et al. | Site-specific introduction of an acetyl-lysine mimic into peptides and proteins by cysteine alkylation | |
Shannon et al. | Investigating the proteome reactivity and selectivity of aryl halides | |
McGinty et al. | Structure–activity analysis of semisynthetic nucleosomes: mechanistic insights into the stimulation of Dot1L by ubiquitylated histone H2B | |
Montgomery et al. | Chemoproteomic profiling of lysine acetyltransferases highlights an expanded landscape of catalytic acetylation | |
Theillet et al. | Site-specific mapping and time-resolved monitoring of lysine methylation by high-resolution NMR spectroscopy | |
Luo et al. | Activity-based protein profiling reagents for protein arginine deiminase 4 (PAD4): synthesis and in vitro evaluation of a fluorescently labeled probe | |
Xie et al. | Chemical probes reveal sirt2’s new function as a robust “eraser” of lysine lipoylation | |
Olia et al. | Nonenzymatic protein acetylation detected by NAPPA protein arrays | |
Park et al. | The PHD3 domain of MLL acts as a CYP33-regulated switch between MLL-mediated activation and repression | |
Roessler et al. | A novel continuous assay for the deacylase sirtuin 5 and other deacetylases | |
Dhall et al. | Chemically sumoylated histone H4 stimulates intranucleosomal demethylation by the LSD1–CoREST complex | |
Zheng et al. | Clickable analogue of cerulenin as chemical probe to explore protein palmitoylation | |
Wang et al. | Structural basis of sirtuin 6-catalyzed nucleosome deacetylation | |
Boskovic et al. | Inhibition of zinc-dependent histone deacetylases with a chemically triggered electrophile | |
Rajabi et al. | Dethioacylation by sirtuins 1–3: considerations for drug design using mechanism-based sirtuin inhibition | |
Hewitt et al. | Development of ubiquitin variants with selectivity for ubiquitin C-terminal hydrolase deubiquitinases | |
Zhang et al. | Site-selective phosphoglycerate mutase 1 acetylation by a small molecule | |
Leurs et al. | Dissecting the binding mode of low affinity phage display peptide ligands to protein targets by hydrogen/deuterium exchange coupled to mass spectrometry | |
Henry et al. | Interaction with the DNA repair protein thymine DNA glycosylase regulates histone acetylation by p300 | |
Lin et al. | Characterization of protein serotonylation via bioorthogonal labeling and enrichment |